PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026ChemistrySelect0 citations

Dual‐Stage Mismatch Interrogation (DMI) for High‐Fidelity G–T Discrimination by a DNA Nanodevice

View Full Paper
CPChristina PatraDKDaria P. KisarevaAEA.A. Eldeeb

Key Points

  • This research aims to enhance the discrimination of G–T mismatches to improve SNV recognition processes.
  • Developed CAPDV, a modular DNA nanodevice, featuring two functional modules.
  • Module 1 selectively excises RNA containing mutations using paired DNAzymes.
  • Module 2 conducts a second interrogation of the mutation and activates RNase H for specific RNA cleavage.
  • Achieved 94% differentiation of G–T mismatches using the integrated CAPDV.
  • The dual-stage approach substantially improved recognition selectivity compared to individual modules.

Abstract

ABSTRACT Precise discrimination of single‐nucleotide variants (SNVs) under physiological conditions remains a significant challenge for nucleic acid technologies, particularly in the case of G>A mutations, where relatively stable G–T mismatches substantially reduce recognition selectivity. Here, we report a modular DNA nanodevice, termed CAPDV (Cut and Paste nanoDevice), that achieves high‐fidelity SNV recognition through a novel concept referred to as dual‐stage mismatch interrogation (DMI). CAPDV incorporates two functional modules. Module 1 selectively excises an RNA fragment containing the mutation using paired DNAzymes. The excised fragment is subsequently transferred to Module 2, where a second round of mutation interrogation occurs. This step is followed by excised fragment‐dependent cleavage of specific RNA sequence by RNase H. While each module individually exhibits limited selectivity, their integration within a CAPDV enables nearly perfect 94% differentiation of G–T mismatch. The DMI mechanism enhances overall recognition selectivity and may serve as a novel strategy for improving selectivity in challenging cases of SNV recognition.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Patra et al. (2026) studied this question.

synapsesocial.com/papers/6a0d50f3f03e14405aa9d160https://doi.org/10.1002/slct.73492
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Making target sites in large structured RNAs accessible to RNA-cleaving DNAzymes through hybridization with synthetic DNA oligonucleotides2024 · 18 citations
  2. 2Reconfigurable Nucleic Acid Nanoparticles with Therapeutic RNAi Responses to Intracellular Disease Markers2025 · 6 citations
  3. 3Programming Aggregate States of DNA Nanorods with Sub-10 nm Hydrophobic Patterns for Tunable Cell Entry2023 · 9 citations
  4. 4GOLGA8 increases bulk antisense oligonucleotide uptake and activity in mammalian cells2023 · 15 citations
  5. 5Thermodynamics and NMR of Internal G·T Mismatches in DNA1997 · 632 citations